跳至主要内容
临床试验/CTRI/2022/08/044783
CTRI/2022/08/044783已完成2 期

EVALUATION OF EFFICACY AND SAFETY OF TOPICAL OXYMETAZOLINE 0.1% IN TREATMENT OF ACQUIRED PTOSIS

DR RPCENTRE FOR OPHTHALMIC SCIENCES0 个研究点目标入组 20 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.PATIENT WITH ACQUIRED PTOSIS
  • 2.PATIENT WITHOUT HISTORY OF PTOSIS CORRECTION
  • 3.PATIENT OR PARENTS WILLING TO GIVE CONSENT

排除标准

  • 1.PATIENTS DIAGNOSED AS CONGENITAL PTOSIS
  • 2.PATIENTS WITH HORNER SYNDROME
  • 3.PATIENTS WITH MYASTHENIA GRAVIS
  • 4.PATIENTS HAVING MECHANICAL PTOSIS
  • 5.PATIENTS WITH PSEUDOPTOSIS
  • 6.PATIENTS WITH CEREBRAL OR CORONARY INSUFFICIENCY
  • 7.SJOGREN SYNDROME PATIENTS
  • 8.HYPERTENSIVE PATIENTS
  • 9.GLAUCOMA PATIENTS
  • 10.PATIENTS ON BETA BLOCKERS
  • 11.PATIENTS ON ALPHA ADRENERGIC AGONISTS
  • 12.PATIENTS ON CARDIAC GLYCOSIDES
  • 13.PATIENTS ON MONOAMINE OXIDASE INHIBITORS
  • 14.PATIENTS NOT WILLING TO FOLLOW UP

研究者

发起方
DR RPCENTRE FOR OPHTHALMIC SCIENCES

相似试验